NCT06025084

Brief Summary

Dentin hypersensitivity is one of the most commonly occurring clinical dental conditions which is characterized by short and sharp pain which arises from exposed dentin in response to external stimuli, which typically are thermal, evaporative, tactile, osmotic or chemical. Hypersensitive dentin is mostly found in buccal tooth areas, in which enamel is missing because of abrasion, attrition, or erosion. The most generally accepted theory regarding the mechanism of dentin hypersensitivity is the hydrodynamic theory. It proposes that a pain-provoking stimulus increases the flow of the dentinal tubular fluid and consequently, stimulates the nerves around the odontoblasts, leading to dentin hypersensitivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Dec 2022

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2023

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 6, 2023

Completed
Last Updated

September 6, 2023

Status Verified

August 1, 2023

Enrollment Period

3 months

First QC Date

August 29, 2023

Last Update Submit

August 29, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of dentin hypersensitivity

    The pain response will be assessed using the numerical Visual Analogue Scale (VAS, range 0-10), with 0 indicating 'no pain' and 10 indicating 'intolerably severe pain.

    from baseline to 2 months after the treatment day.

Study Arms (2)

first group (A1)

ACTIVE COMPARATOR

About 24 patients hypersensitive teeth. So the hypersensitive teeth will be treated with egg shell nanoparticles

Drug: Egg Shell nanoparticles

second group (A2)

ACTIVE COMPARATOR

About 24 patients hypersensitive teeth. treated with the combination therapy of eggshell and TiO2.

Drug: Egg Shell nanoparticles

Interventions

Evaluate the effects of egg shell nanoparticles combined with Titanium dioxide nanoparticles in the treatment of dentin hypersensitivity at different time intervals.

Also known as: Titanium dioxide nanoparticles
first group (A1)second group (A2)

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • For patients;
  • Age between 20 and 55 years
  • Patients in good systemic health with clinically elicitable dentin hypersensitivity
  • Absence of contraindications to the proposed therapies as allergy. 2 - For teeth;
  • Absence of local pathologies (e.g., caries and fractures)
  • Visual analog scale (VAS) score ≥3

You may not qualify if:

  • \-- For patients;
  • Use of any desensitizing toothpaste for previous 3 or 4 months.
  • Taking analgesics/anti-inflammatory drugs at the time of the study, pregnancy, and smoking.
  • For teeth ;
  • Teeth with abrasion and attrition.
  • Carious lesions on the selected or neighboring teeth, defective restorations
  • Any professional desensitizing therapy on the selected teeth during the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistary - Al-Azhar University

Cairo, Egypt

Location

MeSH Terms

Conditions

Dentin Sensitivity

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Officials

  • Fatma Hussein, Lecturer

    Al-Azhar Faculty of Dentistary for girls

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2023

First Posted

September 6, 2023

Study Start

December 1, 2022

Primary Completion

March 15, 2023

Study Completion

March 30, 2023

Last Updated

September 6, 2023

Record last verified: 2023-08

Locations